ACS Nano · 2012 · 175 citations · 49 references
PharmacyOncologyPharmaceuticsDrug DeliveryNanomaterialsNanotechnologyCancer Drug DeliveryCancer NanomedicineNanomedicineNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsAnticancer ChemotherapyLiposomal NanocarriersLiposome Drug DeliveryLiposome Drug ReleaseMagnetic Nanoparticle Drug CarriersMagnetic Nanoparticle Drug DeliveryMultifunctional NanoparticlesNanoparticle-based Chemotherapy
While nanoparticles maximize the amount of chemotherapeutic drug in tumors relative to normal tissues, nanoparticle-based drugs are not accessible to the majority of cancer cells because nanoparticles display patchy, near-perivascular accumulation in tumors. To overcome the limitations of current drugs in their molecular or nanoparticle form, we developed a nanoparticle based on multicomponent nanochains to deliver drug to the majority of cancer cells throughout a tumor while reducing off-target delivery. The nanoparticle is composed of three magnetic nanospheres and one doxorubicin-loaded liposome assembled in a 100 nm long chain. These nanoparticles display prolonged blood circulation and significant intratumoral deposition in tumor models in rodents. Furthermore, the magnetic particles of the chains serve as a mechanical transducer to transfer radio frequency energy to the drug-loaded liposome. The defects on the liposomal walls trigger the release of free drug capable of spreading throughout the entire tumor, which results in a widespread anticancer effect.
49
Shape effects of filaments versus spherical particles in flow and drug delivery
Yan Geng, Paul Dalhaimer, Shenshen Cai et al. · Nature Nanotechnology · 2007 · 2.5K citations · Full text